GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bliss GVS Pharma Ltd (NSE:BLISSGVS) » Definitions » Market Cap

Bliss GVS Pharma (NSE:BLISSGVS) Market Cap : ₹11,118 Mil (As of Jun. 17, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Bliss GVS Pharma Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Bliss GVS Pharma's share price for the quarter that ended in Mar. 2024 was ₹112.85. Bliss GVS Pharma's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 105 Mil. Therefore, Bliss GVS Pharma's market cap for the quarter that ended in Mar. 2024 was ₹11,814 Mil.

Bliss GVS Pharma's quarterly market cap increased from Sep. 2023 (₹9,307 Mil) to Dec. 2023 (₹13,050 Mil) but then declined from Dec. 2023 (₹13,050 Mil) to Mar. 2024 (₹11,814 Mil).

Bliss GVS Pharma's annual market cap declined from Mar. 2022 (₹7,994 Mil) to Mar. 2023 (₹7,410 Mil) but then increased from Mar. 2023 (₹7,410 Mil) to Mar. 2024 (₹11,814 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Bliss GVS Pharma's Enterprise Value for Today is ₹9,845 Mil.


Bliss GVS Pharma Market Cap Historical Data

The historical data trend for Bliss GVS Pharma's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bliss GVS Pharma Market Cap Chart

Bliss GVS Pharma Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10,392.06 10,165.14 7,993.57 7,410.49 11,814.38

Bliss GVS Pharma Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7,410.49 8,363.90 9,307.17 13,049.73 11,814.38

Competitive Comparison of Bliss GVS Pharma's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Bliss GVS Pharma's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bliss GVS Pharma's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bliss GVS Pharma's Market Cap distribution charts can be found below:

* The bar in red indicates where Bliss GVS Pharma's Market Cap falls into.



Bliss GVS Pharma Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Bliss GVS Pharma's Market Cap for the fiscal year that ended in Mar. 2024 is calculated as

Market Cap (A: Mar. 2024 )=Share Price (A: Mar. 2024 )*Shares Outstanding (EOP) (A: Mar. 2024 )
=₹112.85*104.691
=₹11,814

Bliss GVS Pharma's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )=Share Price (Q: Mar. 2024 )*Shares Outstanding (EOP) (Q: Mar. 2024 )
=₹112.85*104.691
=₹11,814

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bliss GVS Pharma  (NSE:BLISSGVS) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Bliss GVS Pharma Market Cap Related Terms

Thank you for viewing the detailed overview of Bliss GVS Pharma's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Bliss GVS Pharma (NSE:BLISSGVS) Business Description

Traded in Other Exchanges
Address
Saki Vihar Road, 102, Hyde Park, Andheri (East), Mumbai, MH, IND, 400 072
Bliss GVS Pharma Ltd is an India-based company engaged in the manufacturing, marketing, trading, and export of pharmaceutical products. Geographically, it derives a majority of revenue from Outside India. Some of its brands include Lonart, P-Alaxin, Funbact, and Lofnac, and others. It offers pharma products including tablets, suspensions, suppositories, and injections. The majority of its revenue is derived from Exports.

Bliss GVS Pharma (NSE:BLISSGVS) Headlines

No Headlines